Lv1
44 积分 2026-02-09 加入
Blockade of PD‐1 and CTLA‐4: A potent immunotherapeutic approach for hepatocellular carcinoma
1个月前
已完结
Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer
1个月前
已完结
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
1个月前
已完结
CTLA-4 Control over Foxp3 + Regulatory T Cell Function
1个月前
已完结
At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
1个月前
已关闭
ctDNA-guided adjuvant therapy in stage II colon cancer: a step forward, but not the final word
2个月前
已完结
Treatment Delays in Early Age–Onset Colorectal Cancer
2个月前
已完结
Promising advances in the treatment of malignant pancreatic endocrine tumors
2个月前
已完结
Incidence trend of neuroendocrine tumors and disparities by sex and race/ethnicity in adults from the United States, 2000–2020
2个月前
已关闭
皖公网安备34019202002308
